NCT02614183 Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study Status COMPLETED Phase PHASE3
NCT02609945 Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults Status COMPLETED Phase PHASE1
NCT02583581 Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks Status UNKNOWN Phase NA
NCT02582996 Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks Status SUSPENDED Phase PHASE3
NCT02542605 To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients Status COMPLETED Phase PHASE1
NCT02532023 The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients Status UNKNOWN Phase PHASE4
NCT02486276 The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache Status COMPLETED Phase NA
NCT02485340 The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache Status COMPLETED Phase NA
NCT02483585 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention Status COMPLETED Phase PHASE3
NCT02472418 Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches Status COMPLETED Phase PHASE2
NCT02468622 Transcriptomic and Biochemical Changes During a Migraine Attack Status COMPLETED Phase N/A
NCT02458326 Aerobic Training Effect on the Improvement of Pain Perception in Patients With Fibromyalgia and Migraine Status UNKNOWN Phase PHASE1
NCT02456740 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention Status COMPLETED Phase PHASE3